C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/16/2006	US20060258590 Chimeric peptide: antagonist, endogeneous ligand binding to protein; therapy for metabolism disorders; obesity
11/16/2006	US20060258587 Modified MscL protein channel
11/16/2006	US20060258586 Compositions and uses of secreted polypeptide, Zsig98
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258583 Anti-angiogenic peptides for treating or preventing endometriosis
11/16/2006	US20060258577 Antiviral agents for the treatment, control and prevention of infections by coronaviruses
11/16/2006	US20060258576 Gdnf-related neuropeptides
11/16/2006	US20060258574 Novel compositions and methods for the treatment of psoriasis
11/16/2006	US20060258572 Somatostatin-dopamine chimeric analogs
11/16/2006	US20060258570 Decorin proteoglycan inhibitor of fibrinogen blood clotting
11/16/2006	US20060258569 Compounds and methods for treating cancer
11/16/2006	US20060258567 Xcrf polynucleotides and polypeptides and uses thereof
11/16/2006	US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006	US20060257984 Hybrid enzymes
11/16/2006	US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/16/2006	US20060257974 Vaccinia virus vector comprising a nucleic acid encoding a fusion protein amino acid sequence consisting of Vif, Vpr, Vpu, Vpx, Rev, Tat, and Nef; genetic vaccines for treating viral diseases
11/16/2006	US20060257971 Antibodies to pro1561 polypeptide
11/16/2006	US20060257970 Human HAC3
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257953 Artificial antibody polypeptides
11/16/2006	US20060257947 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents
11/16/2006	US20060257940 Transformed Shigella
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257921 Novel nucleic acid molecules and polypeptides encoding baboon TAFI
11/16/2006	US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof
11/16/2006	US20060257913 Genetic polymorphisms associated with myocardial infarction and uses thereof
11/16/2006	US20060257912 Methods and sequences to suppress primate huntington gene expression
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/16/2006	US20060257889 Ribonuclease resistant RNA preparation and utilization
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257880 Gastric and prostate cancer associated antigens
11/16/2006	US20060257869 for stimulation of angiogenesis
11/16/2006	US20060257868 Tissue specific genes and gene clusters
11/16/2006	US20060257865 Method for identification and development of therapeutic agents
11/16/2006	US20060257856 Heterodimeric receptor libraries using phagemids
11/16/2006	US20060257852 Severe acute respiratory syndrome coronavirus
11/16/2006	US20060257843 Kappa-PVIIA-related conotoxins as organ protectants
11/16/2006	US20060257500 TRPC6 involved in glomerulonephritis
11/16/2006	US20060257479 Long-acting molecules in sustained release formulations
11/16/2006	US20060257429 Vaccine for periodontal disease
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257424 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines
11/16/2006	US20060257421 Pneumolysin derivatives
11/16/2006	US20060257420 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257417 Vaccine antigens of Moraxella
11/16/2006	US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006	US20060257409 Breast Specific Genes and Proteins
11/16/2006	US20060257408 Method for influencing kinase pathways with IL-22
11/16/2006	US20060257399 Mixture comprising n-glycan modified antibodies exhibiting increased antibody-dependent cellular cytoxicity (ADCC); targeted destruction of tumor cells
11/16/2006	US20060257381 Method for transplanting lymphohematopoietic cells into mammal
11/16/2006	US20060257376 Improves the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function
11/16/2006	US20060257369 Therapeutic regimen for treating cancer
11/16/2006	US20060257366 Chimeric glycoproteins and pseudotyped lentiviral vectors
11/16/2006	US20060257364 Materials and methods for inhibition of IgE production
11/16/2006	US20060257361 Novel form of interleukin-15, Fc-IL-15, and methods of use
11/16/2006	US20060257360 Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
11/16/2006	US20060257356 Administering EBV peptide epitope for eliciting an immune response against EBV; therapy and prophylaxis of lymphoproliferative disorders
11/16/2006	US20060257318 Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
11/16/2006	DE102005023155A1 Albuminlösung Albumin solution
11/16/2006	DE102005019302A1 Carrier zum Targeting von Nervenzellen Carrier for targeting neurons
11/16/2006	CA2651376A1 Method for diagnosis and treatment of a mental disease
11/16/2006	CA2608379A1 Erythropoietin variants
11/16/2006	CA2608316A1 Vaccine composition
11/16/2006	CA2608281A1 New purification method of lactoferrin
11/16/2006	CA2608271A1 Milk fat globule epidermal growth factor-factor viii and sepsis
11/16/2006	CA2607954A1 Conjugate for targeting of drug
11/16/2006	CA2607863A1 Affinity adsorbents for fibrinogen
11/16/2006	CA2607858A1 Affinity adsorbents for factor viii and von willebrand's factor
11/16/2006	CA2607806A1 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	CA2607588A1 Il-31 monoclonal antibodies and methods of use
11/16/2006	CA2607566A1 Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
11/16/2006	CA2606287A1 Peptide
11/15/2006	EP1722229A1 Method of assessing risk of and predisposition to the development of a pathology related to the presence of anti-epcr antibodies
11/15/2006	EP1721987A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
11/15/2006	EP1721986A1 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
11/15/2006	EP1721982A1 Chimeric lyssavirus nucleic acids and polypeptides
11/15/2006	EP1721981A1 Recombinant varicella-zoster virus
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006	EP1721977A2 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
11/15/2006	EP1721976A1 Modified promoter
11/15/2006	EP1721972A2 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna
11/15/2006	EP1721971A1 Screening method
11/15/2006	EP1721909A1 Growth factor mutants with altered biological attributes
11/15/2006	EP1721166A1 Methods for screening insecticides
11/15/2006	EP1721165A2 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
11/15/2006	EP1721162A1 Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a
11/15/2006	EP1721008A2 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
11/15/2006	EP1720995A2 Methods and compostions for targeted cleavage and recombination
11/15/2006	EP1720990A2 High efficiency peptide production in plant cells
11/15/2006	EP1720979A1 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
11/15/2006	EP1720977A1 L-glutamic acid-producing microorganism and a method for producing l-glutamic acid
11/15/2006	EP1720911A1 Fusion protein comprising tatdmt polypeptide
11/15/2006	EP1720905A2 Methods for generating immunity to antigen
11/15/2006	EP1720904A1 Treating or preventing extracellular matrix build-up
11/15/2006	EP1720903A1 Corticotropin-releasing factor receptor 1 (crfr1) agonist polypeptides
11/15/2006	EP1720902A1 Mutein of a bone morphogenetic protein and use thereof
11/15/2006	EP1720901A1 Polypeptide having function of cinnamyl alcohol dehydrogenase, a polynucleotide coding the polypeptide and those uses

1 ... 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 ... 2916